Rp. Degroot et al., PHOSPHORYLATION AND NEGATIVE REGULATION OF THE TRANSCRIPTIONAL ACTIVATOR CREM BY P34CDC2, Molecular endocrinology, 7(11), 1993, pp. 1495-1501
Transcription factors that bind to cAMP-responsive elements (CREs) reg
ulate the expression of target genes in response to activation of the
adenylyl cyclase pathway. It is generally thought that activation is o
btained through direct phosphorylation by the cAMP-dependent protein k
inase-A. We have isolated the gene CRE modulator (CREM), which encodes
multiple members of the CRE-binding protein family, by cell-specific
alternative splicing. Various isoforms have been characterized, encodi
ng both repressors (CREM alpha, -beta, and -gamma) as well as activato
rs (CREM tau). Here we show that the function of the activator CREM ta
u is regulated by the p34(cdc2) kinase. Multiple serine and threonine
residues are phosphorylated in vivo as well as in vitro by p34(cdc2).
Although there is no effect of p34(cdc2)-mediated phosphorylation on C
REM tau DNA binding, we observed a dramatic effect on the trans-regula
tory function. Coexpression of a constitutively active p34(cdc2) mutan
t shows that the trans-activation potential of CREM tau is strongly re
duced by p34(cdc2). This represents the first example of negative regu
lation of a transcription factor of this class by p34(cdc2).